SAN FRANCISCO, Jan. 14, 2020 /PRNewswire/ -- Gladstone researchers, in collaboration with Genentech, a member of the Roche group, have shown therapeutic efficacy of a new experimental drug in mouse models of Alzheimer's disease and a rare genetic form of epilepsy known as Dravet syndrome....
from PR Newswire: https://ift.tt/35S0XR4
No comments:
Post a Comment